TONKA Versus Legalon for Lowering Hepatic Enzymes in Liver Function Disorder Patients.

Summary

The purpose of this study is to evaluate the efficacy TONKA on the reduction of ALT and AST in moderate to severe liver enzyme elevated patients; compared with Silymarin (Legalon) after 6 weeks of treatment.

Timeline

Start

2017-06-15

Primary completion

2019-06-30

Completion

2019-09-30

Drugs

Indications